Search results for "premature ejaculation"

showing 6 items of 6 documents

Premature ejaculation: Pharmacotherapy vs group psychotherapy alone or in combination

2017

Objectives: Premature Ejaculation (PE), the commonest sexual dysfunction in males, is generally treated with local anesthetic and SSRI (Dapoxetine). The aim of our study was investigate Group Psychotherapy as an alternative treatment for PE and compare the efficacy of pharmacological treatment and psychotherapy, either alone or in combination, in terms of response and improved Quality of Life (QoL). From a male outpatient population screened for PE, those who received a diagnosis of PE were proposed for the study, enrolled and divided into 3 groups (A, B and C). Each group was treated with Dapoxetine, Group Psychotherapy alone and Dapoxetine and Group Psychotherapy, respectively. Materials …

AdultMaleBenzylaminesmedicine.medical_specialtyEjaculationUrologymedicine.medical_treatmentPopulation030209 endocrinology & metabolismNaphthaleneslcsh:RC870-923Settore MED/24 - UrologiaGroup psychotherapyYoung Adult03 medical and health sciences0302 clinical medicineQuality of lifeGroup psychotherapyInternal medicinePremature ejaculationHumansMedicineeducationPsychiatryAgedPremature ejaculationeducation.field_of_studybusiness.industryMiddle Agedlcsh:Diseases of the genitourinary system. UrologyDapoxetineCombined Modality TherapyPsychotherapyDapoxetineSexual therapySexual dysfunctionPsychotherapy GroupAnxietymedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugArchivio Italiano di Urologia e Andrologia
researchProduct

Compliance to therapy with Dapoxetine in patients affected by Premature Ejaculation

2012

Introduction Premature ejaculation (PE) is a sexual dysfunction with high prevalence. According to some reports, it is present in about 20-30% of the male population. Since 2009 PE has been treated with a novel inhibitor of serotonin re-uptake, Dapoxetine, which has been reported to be specifically active for PE. Materials and Methods 59 patients have been selected among the patients affected by PE observed at the outpatient department of Urology and Andrology of the “Paolo Giaccone” University Policlinic Hospital of Palermo. Diagnosis was confirmed unequivocally in all patients, who were suitable for drug treatment and accepted to participate in the study. They were divided in 2 groups: on…

AdultMalemedicine.medical_specialtyBenzylaminespremature ejaculation dapoxetine Cytalopram compliance side effectsAdolescentGastrointestinal DiseasesMigraine DisordersComorbidityCitalopramCitalopramNaphthalenesMedication AdherenceSettore MED/24 - UrologiaDrug treatmentYoung AdultInternal medicineSurveys and QuestionnairesPremature ejaculationmedicineOutpatient clinicHumansIn patientPremature EjaculationEiaculazione precoce dapoxetina citalopram compliance effetti collateraliLife StyleAgedGynecologyHigh prevalencebusiness.industryGeneral MedicineMiddle AgedPatient Acceptance of Health CareDapoxetineSexual dysfunctionmedicine.symptomNervous System DiseasesbusinessSelective Serotonin Reuptake Inhibitorsmedicine.drug
researchProduct

Brain Cortical Complexity and Subcortical Morphometrics in Lifelong Premature Ejaculation

2020

Premature ejaculation (PE) is the most common male sexual dysfunction. The brain disturbances that cause this disorder remain poorly understood. This study aimed to investigate how the morphology of cortical and subcortical brain structures differed in PE, how these morphologic differences were associated with severity measures of PE, such as intravaginal ejaculatory latency time (IELT), and how these cortical and subcortical structures were causally connected through mediation analysis. Anatomical MRI scans were acquired from 39 male participants, 23 with PE (28.78 ± 4.32 years), and 16 without PE (27.88 ± 3.65 years). We used a subcortical analysis package within FSL to perform subcortica…

Thalamusgyrification index050105 experimental psychologylcsh:RC321-57103 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePremature ejaculationmorphologymedicine0501 psychology and cognitive sciencesStatistical analysisRight nucleus accumbensmediation analysislcsh:Neurosciences. Biological psychiatry. NeuropsychiatryGyrificationBiological PsychiatryOriginal ResearchMorphometricsbusiness.industry05 social sciencesHuman NeuroscienceAnatomyComputational anatomyEjaculatory latencypremature ejaculationPsychiatry and Mental healthNeuropsychology and Physiological PsychologyNeurologymedicine.symptombusiness030217 neurology & neurosurgeryvertex analysisFrontiers in Human Neuroscience
researchProduct

Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: The PAUSE study

2014

Abstract Background Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program. Objective To characterize the safety profile of dapoxetine in PE treatment and to report the incidence, severity, and type of adverse events. Design, setting, and participants We conducted a 12-wk, open-label, observational study with a 4-wk, postobservational contact. A total of 10 028 patients were enrolled, with 6712 patients (67.6%) treated with dapoxetine 30–60mg (group A)and 3316 (32.4%) treated with alternative care/nondapoxetine (group B). …

AdultComplementary TherapiesMalemedicine.medical_specialtyBenzylaminesAdolescentNauseaUrologyNaphthalenesDapoxetine Safety Cardiovascular events SyncopeSyncopeCardiovascular eventsYoung AdultInternal medicinePremature ejaculationmedicine80 and overCardiovascular events; Dapoxetine; Safety; Syncope; Adolescent; Adult; Aged; Aged 80 and over; Benzylamines; Complementary Therapies; Humans; Male; Middle Aged; Naphthalenes; Premature Ejaculation; Prospective Studies; Serotonin Uptake Inhibitors; Young AdultHumansProspective StudiesPremature EjaculationAdverse effectProspective cohort studyCardiovascular events; Safety; DapoxetineAgedCardiovascular events; Dapoxetine; Safety; Syncope; UrologyAged 80 and overSertralinebusiness.industrySettore MED/24 - UROLOGIAIncidence (epidemiology)Cardiovascular events; Dapoxetine; Safety; Syncope; Adolescent; Adult; Aged; Aged 80 and over; Benzylamines; Complementary Therapies; Humans; Male; Middle Aged; Naphthalenes; Premature Ejaculation; Prospective Studies; Serotonin Uptake Inhibitors; Young Adult; UrologyMiddle AgedDapoxetineCardiovascular events; Dapoxetine; syncope; SafetyDapoxetineAnesthesiaSerotonin Uptake InhibitorsObservational studymedicine.symptomSafetybusinessSelective Serotonin Reuptake Inhibitorsmedicine.drugCardiovascular events Dapoxetine Safety Syncope
researchProduct

246 Premature ejaculation: Comparison of treatment. Pharmacotherapy vs pharmacotherapy in association with group psychotherapy vs group psychotherapy

2015

Group psychotherapymedicine.medical_specialtyPharmacotherapybusiness.industryUrologymedicine.medical_treatmentPremature ejaculationmedicinemedicine.symptomAssociation (psychology)businessPsychiatryEuropean Urology Supplements
researchProduct

Sexual dysfunction in dialytic patients. A prospective cross-sectional observational study in two hemodialysis centers

2020

Objectives: Incidence and prevalence of patients in dialytic therapy increased considerably in recent years. The onset of new issues, once overshadowed, linked to a lower quality of life like sexual dysfunction became increasingly common. The first study in this area, dating back to the 1970s, shows the high prevalence of sexual dysfunction among patients in dialytic therapy of both sexes. Later studies proved an association of sexual dysfunction with psyche disorders, anxiety, depression and lack of self-confidence. The aim of this study is to describe the incidence of male and female sexual main dysfunctions, the latter not least in literature, in patients in hemodialytic therapy. With th…

Malemedicine.medical_specialtyUrologymedia_common.quotation_subjectEnd-Stage Renal DiseasePopulation030232 urology & nephrologyErectile disorderOrgasmEnd stage renal disease03 medical and health sciences0302 clinical medicineErectile DysfunctionRenal DialysisSurveys and QuestionnairesInternal medicinePremature ejaculationmedicineHumansProspective StudiesFemale sexual dysfunctionseducationDialysis End-Stage Renal Disease Sexual male dysfunction Erectile disorder Premature ejaculation Female sexual dysfunctions International Index of Erectile Function Premature EjaculationAgedmedia_commoneducation.field_of_studyPremature ejaculation030219 obstetrics & reproductive medicinebusiness.industryIncidence (epidemiology)Middle Agedmedicine.diseaseSexual male dysfunctionDiseases of the genitourinary system. UrologyCross-Sectional StudiesSexual dysfunctionErectile dysfunctionQuality of LifeFemaleRC870-923medicine.symptombusinessDialysisKidney disease
researchProduct